---
layout: default
title: Terbutaline
description: "Terbutaline çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 3 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 165
evidence_level: L1
indication_count: 3
---

# Terbutaline

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>3</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Terbutaline è—¥å¸«ç­†è¨˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Terbutaline å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Terbutalineï¼ˆç‰¹å¿…æ—ï¼‰æ˜¯é¸æ“‡æ€§ beta-2 è…ä¸Šè…ºç´ å—é«”ä¿ƒæ•ˆåŠ‘ï¼ŒTxGNN é æ¸¬å…¶å°é˜»å¡æ€§è‚ºç—…å…·ç™‚æ•ˆï¼Œå·²æœ‰å¤§é‡è‡¨åºŠè©¦é©—è­‰æ“šæ”¯æŒã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Terbutaline |
| DrugBank ID | DB00871 |
| å°ç£å•†å“å | å–˜å…‹æ³¨å°„æ¶²ã€ç‰¹å¿…æ—éŒ ã€å¸ƒä¹ƒå¯éŒ ç­‰ |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | æ”¯æ°£ç®¡æ€§æ°£å–˜ã€æ”¯æ°£ç®¡ç‚ã€è‚ºæ°£è…« |
| é æ¸¬æ–°é©æ‡‰ç—‡ | bronchitisã€dry eye syndromeã€obstructive lung disease |
| æœ€é«˜è­‰æ“šç­‰ç´š | **L1**ï¼ˆå¤šå€‹ RCTï¼‰ |
| TxGNN åˆ†æ•¸ | 0.892ï¼ˆé˜»å¡æ€§è‚ºç—…ï¼‰ |



## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. obstructive lung disease</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.96%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>### ä½œç”¨æ©Ÿè½‰æ”¯æŒ</p>

<p>Terbutaline é¸æ“‡æ€§ä½œç”¨æ–¼ beta-2 è…ä¸Šè…ºç´ å—é«”ï¼Œé€ æˆæ”¯æ°£ç®¡å¹³æ»‘è‚Œé¬†å¼›ï¼Œæ“´å¼µæ°£é“ã€‚æ­¤æ©Ÿè½‰å°æ‰€æœ‰é˜»å¡æ€§å‘¼å¸é“ç–¾ç—…ï¼ˆåŒ…æ‹¬æ°£å–˜ã€COPDã€æ…¢æ€§æ”¯æ°£ç®¡ç‚ï¼‰å‡æœ‰æ•ˆã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>### COPD/é˜»å¡æ€§è‚ºç—…ç›¸é—œè©¦é©—ï¼ˆè¶…é 50 é …ï¼‰</p>

<table>
<thead>
<tr>
<th>NCT ç·¨è™Ÿ</th>
<th>è©¦é©—åç¨±</th>
<th>éšæ®µ</th>
<th>ç‹€æ…‹</th>
</tr>
</thead>
<tbody>
<tr>
<td>NCT00239577</td>
<td>æ”¯æ°£ç®¡æ“´å¼µåŠ‘å° COPD æ‚£è€…å‘¼å¸å›°é›£ä¹‹å½±éŸ¿</td>
<td>Phase 4</td>
<td>å·²å®Œæˆ</td>
</tr>
<tr>
<td>NCT00216437</td>
<td>Terbutaline vs Tiotropium åœ¨ COPD æ‚£è€…çš„æ¯”è¼ƒ</td>
<td>Phase 4</td>
<td>å·²å®Œæˆ</td>
</tr>
<tr>
<td>NCT01072396</td>
<td>COPD æ‚£è€…æ”¯æ°£ç®¡æ“´å¼µåŠ‘åæ‡‰æ€§ç ”ç©¶</td>
<td>Phase 4</td>
<td>å·²å®Œæˆ</td>
</tr>
<tr>
<td>NCT00158821</td>
<td>é é˜²é‹å‹•èª˜ç™¼æ”¯æ°£ç®¡ç—™æ”£ç ”ç©¶</td>
<td>Phase 4</td>
<td>å·²å®Œæˆ</td>
</tr>
<tr>
<td>NCT00527072</td>
<td>Formoterol vs Terbutaline åœ¨ COPD æ‚£è€…çš„é•·æœŸæ¯”è¼ƒ</td>
<td>Phase 4</td>
<td>å·²å®Œæˆ</td>
</tr>
<tr>
<td>NCT02275234</td>
<td>COPD æ‚£è€…ä½é™¢æœŸé–“æ”¯æ°£ç®¡æ“´å¼µåŠ‘çµ¦äºˆæ–¹å¼æ¯”è¼ƒ</td>
<td>Phase 4</td>
<td>å·²å®Œæˆ</td>
</tr>
<tr>
<td>NCT01587924</td>
<td>å¸å…¥å‹æ”¯æ°£ç®¡æ“´å¼µåŠ‘å° COPD æ‚£è€…è†ˆè‚ŒåŠŸèƒ½å½±éŸ¿</td>
<td>Phase 4</td>
<td>å·²å®Œæˆ</td>
</tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»</h3>

<p>### COPD ç›¸é—œæ–‡ç»</p>

<p>ç”±æ–¼ Terbutaline ç”¨æ–¼ COPD å·²æ˜¯æˆç†Ÿçš„è‡¨åºŠå¯¦è¸ï¼ŒPubMed æ–‡ç»æ¥µç‚ºè±å¯Œï¼Œä¸»è¦é¡å‹åŒ…æ‹¬ï¼š</p>

<ol>
<li><strong>è—¥æ•ˆå­¸ç ”ç©¶</strong>ï¼šç¢ºèªæ”¯æ°£ç®¡æ“´å¼µæ•ˆæœ</li>
<li><strong>æ¯”è¼ƒç ”ç©¶</strong>ï¼šèˆ‡å…¶ä»– beta-2 ä¿ƒæ•ˆåŠ‘å’ŒæŠ—è†½é¹¼è—¥ç‰©æ¯”è¼ƒ</li>
<li><strong>å®‰å…¨æ€§ç ”ç©¶</strong>ï¼šé•·æœŸä½¿ç”¨çš„å¿ƒè¡€ç®¡å®‰å…¨æ€§</li>
<li><strong>çµ¦è—¥æ–¹å¼ç ”ç©¶</strong>ï¼šå™´éœ§å™¨ vs å¸å…¥å™¨çš„æ•ˆæœæ¯”è¼ƒ</li>
</ol>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. respiratory malformation</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.52%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ2 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00220259" target="_blank">NCT00220259</a></td><td>NA</td><td>COMPLETED</td><td>240</td><td>Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04278404" target="_blank">NCT04278404</a></td><td>N/A</td><td>RECRUITING</td><td>5000</td><td>Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ12 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19793774/" target="_blank">19793774</a></td><td>2009</td><td>Article</td><td>Toxicology and indus</td><td>Do terbutaline- and mold-associated impairments of the brain...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1629507/" target="_blank">1629507</a></td><td>1992</td><td>Article</td><td>The Journal of aller</td><td>A comparative study of the effects of an inhaled corticoster...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3281307/" target="_blank">3281307</a></td><td>1988</td><td>Article</td><td>Thorax</td><td>Subcutaneous adrenaline versus terbutaline in the treatment ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9628312/" target="_blank">9628312</a></td><td>1998</td><td>Article</td><td>Acta paediatrica (Os</td><td>Multiple anomalies, hypokalaemic paralysis and partial sympt...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11813927/" target="_blank">11813927</a></td><td>2001</td><td>Article</td><td>Cardiology in the yo</td><td>Use of terbutaline in the treatment of complete heart block ...</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 7 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. Rienhoff syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.38%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

### å·²æ ¸å‡†ç”¢å“

| è¨±å¯è­‰è™Ÿ | å•†å“å | åŠ‘å‹ | å«é‡ |
|----------|--------|------|------|
| è¡›ç½²è—¥è£½å­—ç¬¬041766è™Ÿ | å–˜å…‹æ³¨å°„æ¶² 0.2mg/mL | æ³¨å°„åŠ‘ | 0.2mg/mL |
| è¡›ç½²è—¥è£½å­—ç¬¬026805è™Ÿ | ç‰¹å¿…æ—éŒ  2.5mg | éŒ åŠ‘ | 2.5mg |
| è¡›ç½²è—¥è£½å­—ç¬¬019714è™Ÿ | å¸ƒä¹ƒå¯éŒ  2.5mg | éŒ åŠ‘ | 2.5mg |
| è¡›ç½²è—¥è£½å­—ç¬¬033582è™Ÿ | ç‰¹å¿…æ—æ¶² | å£æœæ¶² | - |

### å¥ä¿çµ¦ä»˜ç‹€æ…‹

æ‰€æœ‰åŠ‘å‹å‡æœ‰å¥ä¿çµ¦ä»˜ï¼Œå±¬æ–¼åŸºæœ¬å‘¼å¸é“ç”¨è—¥ã€‚

## å®‰å…¨æ€§è€ƒé‡

### è—¥ç‰©äº¤äº’ä½œç”¨

| äº¤äº’ä½œç”¨è—¥ç‰© | åš´é‡ç¨‹åº¦ | èªªæ˜ |
|--------------|----------|------|
| Beta é˜»æ–·åŠ‘ | ä¸­åº¦ | æ‹®æŠ—ä½œç”¨ï¼Œé™ä½ç™‚æ•ˆ |
| MAO æŠ‘åˆ¶åŠ‘ | ä¸­åº¦ | å¯èƒ½å¢å¼·å¿ƒè¡€ç®¡å‰¯ä½œç”¨ |
| ä¸‰ç’°æŠ—æ†‚é¬±åŠ‘ | ä¸­åº¦ | å¯èƒ½å¢å¼·å¿ƒè¡€ç®¡å‰¯ä½œç”¨ |
| åˆ©å°¿åŠ‘ | è¼•åº¦ | å¯èƒ½åŠ é‡ä½è¡€é‰€ |

### ä¸»è¦ä¸è‰¯åæ‡‰

- **å¸¸è¦‹**ï¼šå¿ƒæ‚¸ã€æ‰‹æŠ–ã€é ­ç—›ã€è‚Œè‚‰ç—™æ”£
- **è¼ƒå°‘è¦‹**ï¼šå¿ƒå¾‹ä¸æ•´ã€ä½è¡€é‰€
- **ç½•è¦‹**ï¼šéæ•åæ‡‰

### ç‰¹æ®Šæ—ç¾¤æ³¨æ„äº‹é …

- **å¿ƒè¡€ç®¡ç–¾ç—…**ï¼šè¬¹æ…ä½¿ç”¨ï¼Œç›£æ¸¬å¿ƒç‡
- **ç³–å°¿ç—…**ï¼šå¯èƒ½å½±éŸ¿è¡€ç³–æ§åˆ¶
- **ç”²ç‹€è…ºäº¢é€²**ï¼šå¯èƒ½åŠ é‡ç—‡ç‹€
- **æ‡·å­•**ï¼šCategory Bï¼Œæ›¾ç”¨æ–¼å®‰èƒä½†æœ‰çˆ­è­°


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**å¿ƒè¡€ç®¡ç–¾ç—…** ğŸŸ¡ Moderate
- é¢¨éšªåŒ…æ‹¬ï¼šå¿ƒå¾‹ä¸æ•´ã€‚

**ç³–å°¿ç—…** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚

**Hypokalemia** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šAdrenergic bronchodilators may cause decreases in serum potassium concentrations, primarily when given by nebulization or intravenous administration...

**Seizures** ğŸŸ¡ Moderate
- é¢¨éšªåŒ…æ‹¬ï¼šç™²ç™‡ç™¼ä½œã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### é æ¸¬å¯ä¿¡åº¦è©•ä¼°

| é æ¸¬é©æ‡‰ç—‡ | è­‰æ“šç­‰ç´š | å¯ä¿¡åº¦ | å»ºè­° |
|------------|----------|--------|------|
| é˜»å¡æ€§è‚ºç—…ï¼ˆCOPDï¼‰ | L1 | æ¥µé«˜ | å·²æ˜¯æˆç†Ÿè‡¨åºŠå¯¦è¸ |

### è‡¨åºŠæ‡‰ç”¨å»ºè­°

1. **COPD æ€¥æ€§ç™¼ä½œ**ï¼šå¯ä½œç‚ºçŸ­æ•ˆæ”¯æ°£ç®¡æ“´å¼µåŠ‘ä½¿ç”¨
2. **COPD ç¶­æŒæ²»ç™‚**ï¼šé€šå¸¸å„ªå…ˆé¸ç”¨é•·æ•ˆè£½åŠ‘ï¼ˆLABAï¼‰ï¼ŒTerbutaline ä½œç‚ºå‚™ç”¨
3. **åˆä½µæ°£å–˜çš„ COPD**ï¼šTerbutaline ç‰¹åˆ¥é©åˆ

### å¯¦å‹™è€ƒé‡

Terbutaline ç”¨æ–¼ COPD é›–éã€Œæ–°é©æ‡‰ç—‡ã€ï¼Œä½† TxGNN çš„é æ¸¬è­‰å¯¦å…¶è‡¨åºŠåƒ¹å€¼ã€‚åœ¨å°ç£ï¼ŒTerbutaline ä¸»è¦é©æ‡‰ç—‡æ¨™ç¤ºç‚ºæ°£å–˜å’Œæ”¯æ°£ç®¡ç‚ï¼Œè‹¥èƒ½æ˜ç¢ºç´å…¥ COPD é©æ‡‰ç—‡ï¼Œå°‡ä½¿è™•æ–¹æ›´ç‚ºæ˜ç¢ºã€‚

### èˆ‡å…¶ä»–è—¥ç‰©çš„å®šä½æ¯”è¼ƒ

| è—¥ç‰©é¡åˆ¥ | ä»£è¡¨è—¥ç‰© | å„ªå‹¢ | åŠ£å‹¢ |
|----------|----------|------|------|
| SABAï¼ˆå« Terbutalineï¼‰ | Terbutaline, Salbutamol | å¿«é€Ÿèµ·æ•ˆã€æ€¥æ•‘ç”¨ | ä½œç”¨æ™‚é–“çŸ­ |
| LABA | Formoterol, Salmeterol | ä½œç”¨æ™‚é–“é•· | èµ·æ•ˆè¼ƒæ…¢ |
| LAMA | Tiotropium | 24 å°æ™‚ä½œç”¨ | èµ·æ•ˆè¼ƒæ…¢ |

---

*æœ¬ç­†è¨˜ç”± TxGNN é æ¸¬ç³»çµ±ç”¢ç”Ÿï¼Œåƒ…ä¾›ç ”ç©¶åƒè€ƒï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€‚*
*æ›´æ–°æ—¥æœŸï¼š2026-02-11*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Voriconazole]({{ "/drugs/voriconazole/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Levamisole]({{ "/drugs/levamisole/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Trastuzumab Deruxtecan]({{ "/drugs/trastuzumab_deruxtecan/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Pentosan Polysulfate]({{ "/drugs/pentosan_polysulfate/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Vigabatrin]({{ "/drugs/vigabatrin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Terbutalineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/terbutaline/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_terbutaline,
  title = {Terbutalineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/terbutaline/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
